New York resident Richard DiVenuto has worked as a financial advisor for more than 25 years. Today, Richard DiVenuto is an advisor to biotech firms, which focuses on allogenic cell therapies in treating cancer. Other ventures Mr. DiVenuto is involved in include a new disruptive Edge-Hybrid computing, a company concentrating on cloud-based technologies.
The company is expected to perform well for a few reasons. The technology is one that allows users to operate over long distances, offering accessibility to large data sets. Project edge- ULT X is expected to work best for businesses that operate remotely, privately, or using hybrid-cloud situations.
Project Edge is 20 years old company that have been transformed, dormant until about four years ago. Under new leadership, the company is expected to raise significant capital by December 2021. It expects to be attractive to industries such as oil and gas, weather, fin-tech, and media and entertainment. Project Edge is primed to do well in this market because it has already done much of its work elating to reducing latency over data networks.
Richard DiVenuto 